Daiwa upgraded Edwards Lifesciences (EW) to Outperform from Neutral with an $89 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences Reports Strong Growth and Raises Guidance
- Edwards Lifesciences’ MITRIS Valve Study: A Key Development for Investors
- Edwards Lifesciences price target raised to $101 from $89 at Goldman Sachs
- Edwards Lifesciences price target raised to $95 from $87 at Mizuho
- Early notable gainers among liquid option names on July 25th